European Pharmacopoeia to integrate ICH elemental impurities guide
This article was originally published in SRA
The European Pharmacopoeia Commission is to integrate the international guideline on elemental impurities (ICH Q3D) with related pharmacopoeial texts to ensure there is consistency between the licensing authorities and the European Pharmacopoeia1.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.